Conversations with Panmure Gordon | Daniel Koller, BB Biotech AG

Podcast

Share this post

In the latest episode of Conversations with Panmure Gordon, Daniel Koller, Head of Investment team at BB Biotech joins Julie Simmonds, Healthcare Analyst to explore the current market opportunities in the biotech sector and areas of focus where the company sees the most exciting potential value and growth prospects.

Other insights like this

View all

Insights

Podcast: Panmure Gordon and Gresham House

9th April 2020

Tony Dalwood, CEO of Gresham House, talks to Rae Maile and Phil Dobbin, Financial Services research analysts at Panmure Gordon, about the current market environment, Gresham…
Read more
Listen

Conversations with Panmure Gordon | Relishing Challenges as CEO of the RSA

10th January 2023

Chief Economist and Head of Research at Panmure Gordon, Simon French, was invited to speak with David Buik, Market Commentator and Andy Haldane, Chief…
Read more
Insights

First Thoughts: UK Budget 2021 – 4th March 2021

5th March 2021

Simon French discusses his thoughts on the UK Budget 2021.
Read more
Watch

Key Picks Selection – Dr Mike Mitchell

15th February 2022

Dr Mike Mitchell, Healthcare E: mike.mitchell@panmure.com T: +44 (0)20 7886 2761…
Read more
Insights

Guy Anderson of The Mercantile Investment Trust, interviewed by Simon French

25th June 2021

25/06/21
Read more
Podcast

Chris Hill, CEO, Hargreaves Lansdown

15th February 2021

Rae Maile interviews Chris Hill, CEO, Hargreaves Lansdown.
Read more
Insights

Conversations with Panmure Gordon | Hugh Young, Manger, Aberdeen Standard Asia Focus (AAS)

21st September 2020

21/09/20
Read more
Watch

Key Picks Selection – Lacie Midgley

15th February 2022

Lacie Midgley – New Energy and Clean Tech E: lacie.midgley@panmure.com T: +44 (0)20 7886 2769…
Read more